UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES ACT OF 1934.
Commission File Number: 0-27101
National Boston Medical, Inc.
-------------------------------------------------------
(Exact name of registrant as specified in its charter)
43 Taunton Green, 3rd Floor
Taunton, Massachusetts 02780
(508) 884-8820
---------------------------------------------
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive
offices)
Common Stock, $.01 par value
----------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
-----------------------------------------------------------------------------
(Titles of all other classes of securities for which a
duty to file reports under section 13(a) or 15(d) remain)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [] Rule 12h-3(b)(1)(i) []
Rule 12g-4(a)(1)(ii) [] Rule 12g-3(b)(1)(ii) []
Rule 12g-4(a)(2)(i) [] Rule 12g-3(b)(2)(i) []
Rule 12g-4(a)(2)(ii) [] Rule 12g-3(b)(2)(ii) []
Rule 15d-6 []
Approximate number of holders of record as of the certification or notice
date: 417.
Pursuant to the requirements of the Securities Exchange Act of 1934
National Boston Medical, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized persons.
Date: February 11, 2000 By: /s/ Daniel J. Hoyng
---------------------------------
Daniel J. Hoyng, President
